Martina Anton

6PUBLICATIONS
69CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 21, 2026
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.

Deepti Agrawal, Katarina Cisarova, Sebastian Vosberg

|Jan 29, 2022
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner.

Anna-Lena Meinhardt, Enkhtsetseg Munkhbaatar, Ulrike Höckendorf

|Nov 05, 2021
XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells.

Adam Wahida, Madeleine Müller, Andreas Hiergeist

|May 11, 2021
Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH.

Michael Dudek, Dominik Pfister, Sainitin Donakonda

|Mar 25, 2021
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH.

Michael Dudek, Dominik Pfister, Sainitin Donakonda

|Sep 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.

Enkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal

Pageof 1

Frequent Collaborators

4 joint publications

Katja Steiger

3 joint publications

Mathias Heikenwalder

3 joint publications

Percy A Knolle

3 joint publications

Adam Wahida